Market Place
Sourcing Support
Nutcracker Debuts NMU-Symphony RNA Manufacturing Tech
03 Jun 2025 //
BUSINESSWIRE
Nutcracker Therapeutics to Showcase NMU-Symphony™ Platform
01 May 2025 //
BUSINESSWIRE
Nutcracker Presents Biomanufacturing at Cancer Vaccine Summit
25 Nov 2024 //
BUSINESSWIRE
Nutcracker Launches Precision Biomanufacturing Solutions
12 Nov 2024 //
BUSINESSWIRE
Nutcracker Therapeutics Publishes On Nutshell® Delivery Vehicles
07 Aug 2024 //
BUSINESSWIRE
Nutcracker: Enhanced B-Cell Lymphoma Candidate At ASCO 2024
05 Jun 2024 //
BUSINESSWIRE
Nutcracker To Unveil NTX-472, Present At ASCO, Sachs Forum
16 May 2024 //
BUSINESSWIRE
Biotech naming trends bypass `buzzwords and business speak`
16 Apr 2024 //
FIERCE BIOTECH
Nutcracker`s NTX-470 Enhances Prostate Cancer Activity At AACR
11 Apr 2024 //
BUSINESSWIRE
Nutcracker Therapeutics to Present Data on mRNA Drug Candidate
12 Mar 2024 //
BUSINESSWIRE
Nutcracker Named Industry Veteran Samuel Deutsch as Chief Scientific Officer
08 Jan 2024 //
BUSINESSWIRE
Nutcracker Demonstrates Anti-tumor Responses of Preclinical mRNA Drug Candidates
07 Nov 2023 //
BUSINESSWIRE
Nutcracker Therapeutics to Present Data for mRNA Drug Candidates at SITC 2023
24 Oct 2023 //
BUSINESSWIRE
Nutcracker lays off a dozen staffers after $167M round in 2022
21 Jun 2023 //
FIERCE BIOTECH
Nutcracker appoints Cynthia Collins, biopharma veteran former Editas Med CEO
09 May 2023 //
BUSINESSWIRE
Nutcracker Presenting on Nutshell™ mRNA Delivery Technology at the 2023
02 May 2023 //
BUSINESSWIRE
Nutcracker Therapeutics Demonstrates Immunotherapeutic Potency of Lead mRNA
19 Apr 2023 //
BUSINESSWIRE
Nutcracker Appoints Veteran Angela Peters as Chief Human Resources Officer
07 Mar 2023 //
BUSINESSWIRE
Nutcracker Therapeutics Adds Dr. Thomas J. Dietz to Board of Directors
06 Feb 2023 //
BUSINESSWIRE
Nutcracker Reports Strong Anti-Tumor Responses of Lead mRNA Immunotherapy
11 Nov 2022 //
BUSINESSWIRE
Nutcracker Therapeutics Bolsters Leadership with CPO
22 Jun 2022 //
BUSINESSWIRE
GMP-in-a-box company lands $167M to develop its own cancer drugs
15 Mar 2022 //
ENDPTS
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.